Warning letterFDA · Sep 26, 2024
Supercore Products Group, Inc. MARCS-CMS 690510, September 26, 2024
Named company: Supercore Products Group, Inc.
As described below, these products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a) and 331(d). Furthermore,…
Lot information: not specified in this record.